FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061688 [Registered on: 22/01/2024] Trial Registered Prospectively
Last Modified On: 15/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   EFFECT OF ONE GRAM OF INTRAVENOUS PARACETAMOL GIVEN PRIOR TO ANAESTHESIA ON POST OPERATIVE PAIN MANAGEMENT IN PATIENTS UNDERGOING LAPAROSCOPIC SURGERIES – A RANDOMIZED CONTROL TRIAL  
Scientific Title of Study   EFFECT OF PREEMPTIVE ONE GRAM OF INTRAVENOUS PARACETAMOL ON POST OPERATIVE ANALGESIA IN PATIENTS UNDERGOING LAPAROSCOPIC SURGERIES – A RANDOMIZED CONTROL TRIAL  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bikkina Kesava Phani Kumar  
Designation  Junior Resident, Department of Anaesthesiology 
Affiliation  Mahatma Gandhi Institute of Medical Sciences,Sevagram 
Address  Department of Anaesthesiology,Main Operation Theatre Complex, Mahatma Gandhi Institute of Medical Sciences,Sevagram, Wardha, Maharashtra

Wardha
MAHARASHTRA
442102
India 
Phone  8985564634  
Fax    
Email  kesavbikkina@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Sucheta Tidke 
Designation  Director Professor and HOD,Department of Anaesthesiology 
Affiliation  Mahatma Gandhi Institute of Medical Sciences,Sevagram 
Address  Department of Anaesthesiology, Main Operation Theatre Complex,Mahatma Gandhi Institute of Medical Sciences,Sevagram, Wardha, Maharashtra

Wardha
MAHARASHTRA
442102
India 
Phone  8985564634  
Fax    
Email  suchetatidke@mgims.ac.in  
 
Details of Contact Person
Public Query
 
Name  Bikkina Kesava Phani Kumar  
Designation  Junior Resident, Department of Anaesthesiology 
Affiliation  Mahatma Gandhi Institute of Medical Sciences,Sevagram 
Address  Department of Anaesthesiology, Main Operation Theatre Complex,Mahatma Gandhi Institute of Medical Sciences,Sevagram, Wardha, Maharashtra

Wardha
MAHARASHTRA
442102
India 
Phone  8985564634  
Fax    
Email  kesavbikkina@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha  
 
Primary Sponsor  
Name  Mahatma Gandhi Institute of Medical Sciences, Sevagram  
Address  Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra 442102 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrBikkina Kesava Phani Kumar   Main OT Complex,Kasturba Hospital, Mahatma Gandhi Institute of Medical Sciences, Sevagram   Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra 442102
Wardha
MAHARASHTRA 
8985564634

kesavbikkina@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Mahatma Gandhi Institute of Medical Sciences, Sevagram   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K811||Chronic cholecystitis, (2) ICD-10 Condition: K36||Other appendicitis, (3) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Normal Saline Intravenous Injection   100 millilitres of Normal Saline as placebo to be given over 10 minutes preemptive to laparoscopic procedures in ASA1 and ASA2 patients of age 18-60 years to study its effect on post operative analgesia 
Intervention  Paracetamol One Gram Intravenous Injection  Single Dose of One Gram Intravenous Injection of Paracetamol is given over 10 minutes preemptive in laparoscopic procedures of ASA1 and ASA2 patients of age 18-60 years to study its effect on post operative analgesia 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients aged between 18 and 65 years. 2) Patients scheduled for Elective laparoscopic surgeries. 3) Patients ready to give written informed consent. 4) Patients belonging to ASA Grade-I and II.  
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Post operative analgesia  15 minutes, 30minutes, 1 hour, 2 hours, 4 hours of post operative period 
 
Secondary Outcome  
Outcome  TimePoints 
Complications like Post operative nausea, vomiting and time needed for rescue analgesia  15 minutes, 30 minutes, 1 hour, 2 hours and 4 hours 
 
Target Sample Size   Total Sample Size="44"
Sample Size from India="44" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [to].

  6. For how long will this data be available start date provided 25-01-2024 and end date provided 30-12-2028?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   We are studying the effect of preemptive one gram of intravenous paracetamol on post operative analgesia in patients undergoing laparoscopic surgeries in comparision with 100 millilitres of Normal Saline  
Close